- Investing Ideas
- Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Daiichi Sankyo Company
Market Cap: JP¥4.7t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,567.50
7D
-8.3%
1Y
-30.2%
Sumitomo Pharma
Market Cap: JP¥559.8b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,248.00
7D
-2.8%
1Y
1.0%
GNI Group
Market Cap: JP¥162.9b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,475.00
7D
-4.9%
1Y
-11.4%
PeptiDream
Market Cap: JP¥121.7b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥947.20
7D
0.8%
1Y
-43.3%
Nxera Pharma
Market Cap: JP¥81.1b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥876.00
7D
-3.0%
1Y
-5.1%
SanBio
Market Cap: JP¥71.7b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥919.00
7D
-4.0%
1Y
-61.1%
Fuji Pharma
Market Cap: JP¥48.6b
Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.
4554
JP¥1,861.00
7D
-1.0%
1Y
33.7%
Heartseed
Market Cap: JP¥38.5b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,683.00
7D
0.8%
1Y
-52.7%
Healios K.K
Market Cap: JP¥31.9b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥236.00
7D
-1.3%
1Y
-63.0%
StemRIM
Market Cap: JP¥18.7b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥298.00
7D
-0.3%
1Y
-7.5%
Kidswell Bio
Market Cap: JP¥7.3b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥147.00
7D
3.5%
1Y
-43.9%
Noile-Immune Biotech
Market Cap: JP¥6.0b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥139.00
7D
-1.4%
1Y
-20.1%
TMS
Market Cap: JP¥4.5b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥98.00
7D
3.2%
1Y
-41.3%